HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$1.32
Day range
$1.26 - $1.35
Year range
$1.14 - $4.08
Market cap
347.63M USD
Avg Volume
3.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 57.62M | 23.93% |
Operating expense | 52.74M | 8.80% |
Net income | -12.24M | 46.31% |
Net profit margin | -21.25 | 56.67% |
Earnings per share | -0.05 | 50.00% |
EBITDA | -8.23M | -991.78% |
Effective tax rate | -8.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 184.84M | 256.36% |
Total assets | 376.56M | 70.65% |
Total liabilities | 343.96M | 27.46% |
Total equity | 32.61M | — |
Shares outstanding | 267.88M | — |
Price to book | 11.00 | — |
Return on assets | -5.77% | — |
Return on capital | -9.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.24M | 46.31% |
Cash from operations | 31.13M | 797.02% |
Cash from investing | -7.88M | -393,750.00% |
Cash from financing | -4.85M | -121.72% |
Net change in cash | 18.40M | 3.06% |
Free cash flow | 32.05M | 47.14% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
194
